Presentation is loading. Please wait.

Presentation is loading. Please wait.

Figure 1 Metabolic profiling as a tool for studying rheumatic diseases

Published byKevin Terry Modified over 5 years ago

Similar presentations

Presentation on theme: "Figure 1 Metabolic profiling as a tool for studying rheumatic diseases"— Presentation transcript:

1 Figure 1 Metabolic profiling as a tool for studying rheumatic diseases
Figure 1 | Metabolic profiling as a tool for studying rheumatic diseases. The metabolites in circulation or found in tissues not only reflect the genetic background and the gene expression profile of an individual, but also their lifestyle, diet, medication use and any ongoing pathogenic processes. Integrating metabolic and genetic profiling can help to differentiate between molecular changes observed in patients with rheumatic diseases that are derived from modifiable factors (dynamic changes that respond to diet or medication), and those that are directly linked to an individual's genetic profile. Metabolomics could also monitor the progression of a disease or treatment. Menni, C. et al. (2017) Mixing omics: combining genetics and metabolomics to study rheumatic diseases Nat. Rev. Rheumatol. doi: /nrrheum

Download ppt "Figure 1 Metabolic profiling as a tool for studying rheumatic diseases"

Similar presentations

Integrated Metabolomics and Genomics

Integrated Metabolomics and Genomics
Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol
Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Rheumatol. doi: /nrrheum

Nat. Rev. Rheumatol. doi: /nrrheum
Figure 3 Connexins in cartilage

Figure 3 Connexins in cartilage
Figure 1 Historical evolution of the clinical classification and

Figure 1 Historical evolution of the clinical classification and
Figure 2 A timeline summarizing the development of diagnostic tools in rheumatology Figure 2 | A timeline summarizing the development of diagnostic tools.

Figure 2 A timeline summarizing the development of diagnostic tools in rheumatology Figure 2 | A timeline summarizing the development of diagnostic tools.
Figure 1 Rheumatoid arthritis development over time in relation to the level of inflammation Figure 1 | Rheumatoid arthritis development over time in relation.

Figure 1 Rheumatoid arthritis development over time in relation to the level of inflammation Figure 1 | Rheumatoid arthritis development over time in relation.
Nat. Rev. Rheumatol. doi: /nrrheum

Nat. Rev. Rheumatol. doi: /nrrheum
Nat. Rev. Nephrol. doi: /nrneph

Nat. Rev. Nephrol. doi: /nrneph
Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol
Nat. Rev. Rheumatol. doi: /nrrheum

Nat. Rev. Rheumatol. doi: /nrrheum
Figure 5 Schematic illustration of different clinical trial designs

Figure 5 Schematic illustration of different clinical trial designs
Figure 1 Factors underlying metabolic alterations in osteoarthritis

Figure 1 Factors underlying metabolic alterations in osteoarthritis
Figure 1 Induction of immune tolerance

Figure 1 Induction of immune tolerance
Figure 2 Risk factors for sarcopenia

Figure 2 Risk factors for sarcopenia
Figure 5 Two approaches to therapeutic genome editing

Figure 5 Two approaches to therapeutic genome editing
Nat. Rev. Rheumatol. doi: /nrrheum

Nat. Rev. Rheumatol. doi: /nrrheum
Nat. Rev. Rheumatol. doi: /nrrheum

Nat. Rev. Rheumatol. doi: /nrrheum
Figure 2 Targeted versus untargeted metabolomics approaches

Figure 2 Targeted versus untargeted metabolomics approaches

Similar presentations

Ads by Google